- Home
- ENOV
ENOV
Enovis Corporation
as 02-21-2025 4:00pm EST
Enovis Corp is a medical technology company focused on developing clinically differentiated solutions that generate measurable patient outcomes and transform workflows by manufacturing and distributing high-quality medical devices with a broad use for reconstructive surgery, rehabilitation, pain management, and physical therapy. The company conducts its operations through two operating segments: Prevention & Recovery (P&R) and Reconstructive (Recon). It generates the majority of revenue from the Prevention & Recovery segment.
Upcoming Earnings Alert:
Get ready for potential market movements as Enovis Corporation ENOV prepares to release earnings report on 26 Feb 2025.
| Founded: | 1995 | Country: | United States |
| Employees: | N/A | City: | WILMINGTON |
| Market Cap: | 2.4B | IPO Year: | 2008 |
| Target Price: | $65.86 | AVG Volume (30 days): | 548.0K |
| Analyst Decision: | Buy | Number of Analysts: | 7 |
| Dividend Yield: | N/A | Dividend Payout Frequency: | N/A |
| EPS: | -2.18 | EPS Growth: | N/A |
| 52 Week Low/High: | $38.27 - $63.96 | Next Earning Date: | 02-26-2025 |
| Revenue: | $2,001,668,000 | Revenue Growth: | 20.52% |
| Revenue Growth (this year): | 25.59% | Revenue Growth (next year): | 5.74% |
Latest Enovis Corporation News
ENOV Breaking Stock News: Dive into ENOV Ticker-Specific Updates for Smart Investing
Zacks
2 days ago
Talkspace, Inc. (TALK) Q4 Earnings Meet Estimates
Argus Research
3 days ago
ENOV: What does Argus have to say about ENOV?
Zacks
9 days ago
10x Genomics (TXG) Reports Q4 Loss, Tops Revenue Estimates
Argus Research
17 days ago
ENOV: Lowering target price to $37.00
GlobeNewswire
24 days ago
Enovis to Host Fourth Quarter and Full Year 2024 Results Conference Call on February 26th
Argus Research
24 days ago
ENOV: What does Argus have to say about ENOV?
Zacks
a month ago
Zacks Industry Outlook Enovis, Omnicell and Phreesia
Zacks
a month ago
3 Medical Info Systems Stocks to Buy as Stargate AI Drives Industry Prospects
Compare ENOV vs Leading Stocks
Share on Social Networks:
Disclaimer
The information presented on this page, "ENOV Enovis Corporation - Stocks Price | History | Analysis", including historical data, forecasts, news, insider information, and predictions, is provided for educational purposes only. It should not be considered as financial advice or a recommendation to buy or sell any securities. Decisions regarding investments should be made only after careful consideration and consultation with a qualified financial advisor. We do not endorse or guarantee the accuracy or reliability of the information provided, and we disclaim any liability for financial losses incurred as a result of decisions made based on the information presented.